A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes' Effects on Moms (GEM) study

Assiamira Ferrara, Monique M Hedderson, Cheryl L Albright, Susan D Brown, Samantha F Ehrlich, Bette J Caan, Barbara Sternfeld, Nancy P Gordon, Julie A Schmittdiel, Erica P Gunderson, Ashley A Mevi, Ai-Lin Tsai, Jenny Ching, Yvonne Crites, Charles P Quesenberry Jr, Assiamira Ferrara, Monique M Hedderson, Cheryl L Albright, Susan D Brown, Samantha F Ehrlich, Bette J Caan, Barbara Sternfeld, Nancy P Gordon, Julie A Schmittdiel, Erica P Gunderson, Ashley A Mevi, Ai-Lin Tsai, Jenny Ching, Yvonne Crites, Charles P Quesenberry Jr

Abstract

Background: Women with gestational diabetes (GDM) are at high risk of developing diabetes later in life. After a GDM diagnosis, women receive prenatal care to control their blood glucose levels via diet, physical activity and medications. Continuing such lifestyle skills into early motherhood may reduce the risk of diabetes in this high risk population. In the Gestational Diabetes' Effects on Moms (GEM) study, we are evaluating the comparative effectiveness of diabetes prevention strategies for weight management designed for pregnant/postpartum women with GDM and delivered at the health system level.

Methods/design: The GEM study is a pragmatic cluster randomized clinical trial of 44 medical facilities at Kaiser Permanente Northern California randomly assigned to either the intervention or usual care conditions, that includes 2,320 women with a GDM diagnosis between March 27, 2011 and March 30, 2012. A Diabetes Prevention Program-derived print/telephone lifestyle intervention of 13 telephonic sessions tailored to pregnant/postpartum women was developed. The effectiveness of this intervention added to usual care is to be compared to usual care practices alone, which includes two pages of printed lifestyle recommendations sent to postpartum women via mail. Primary outcomes include the proportion of women who reach a postpartum weight goal and total weight change. Secondary outcomes include postpartum glycemia, blood pressure, depression, percent of calories from fat, total caloric intake and physical activity levels. Data were collected through electronic medical records and surveys at baseline (soon after GDM diagnosis), 6 weeks (range 2 to 11 weeks), 6 months (range 12 to 34 weeks) and 12 months postpartum (range 35 to 64 weeks).

Discussion: There is a need for evidence regarding the effectiveness of lifestyle modification for the prevention of diabetes in women with GDM, as well as confirmation that a diabetes prevention program delivered at the health system level is able to successfully reach this population. Given the use of a telephonic case management model, our Diabetes Prevention Program-derived print/telephone intervention has the potential to be adopted in other settings and to inform policies to promote the prevention of diabetes among women with GDM.

Trial registration: ClinicalTrials.gov NCT01344278.

References

    1. Metzger BE. Summary and recommendations of the third international workshop- conference on gestational diabetes mellitus. Diabetes. 1991;40(Suppl 2):197–201.
    1. Ferrara A, Kahn HS, Quesenberry C, Riley C, Hedderson MM. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol. 2004;103:526–533. doi: 10.1097/01.AOG.0000113623.18286.20.
    1. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773–1779. doi: 10.1016/S0140-6736(09)60731-5.
    1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
    1. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008;93:4774–4779. doi: 10.1210/jc.2008-0772.
    1. Kim C, McEwen LN, Kerr EA, Piette JD, Chames MC, Ferrara A, Herman WH. Preventive counseling among women with histories of gestational diabetes mellitus. Diabetes Care. 2007;10:2489–2495.
    1. Ferrara A, Peng T, Kim C. Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus. A report from the translating research into action for diabetes (TRIAD) study. Diabetes Care. 2009;32(2):269–274. Doi: 10.2337/dc08-1184.
    1. Ferrara A, Hedderson M, Albright CL, Ehrlich SF, Quesenberry CP, Peng T, Feng J, Ching J, Crites YM. A pregnancy and postpartum lifestyle intervention in women with GDM reduces diabetes risk factors: a feasibility randomized control trial. Diabetes Care. 2011;34:1519–1525. doi: 10.2337/dc10-2221.
    1. Ferrara A, Hedderson MM, Ching J, Kim C, Peng T, Crites YM. Referral to telephonic nurse management improves outcomes in women with gestational diabetes. Am J Obstet Gynecol. 2012;206:491–495.
    1. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89:1322–1327. doi: 10.2105/AJPH.89.9.1322.
    1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–2375. doi: 10.1001/jama.285.18.2370.
    1. Committee opinion no. 504: screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol. 2011;118:751–753. doi: 10.1097/AOG.0b013e3182310cc3.
    1. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768–773.
    1. American Diabetes Association. Standards of medical care in diabetes--2013. Diabetes Care. 2013;36(Suppl 1):S11–S66.
    1. Hayes RJ, Moulton LH. Cluster Randomzed Trial. Chapman & Hall/CRC: Boca Raton; 2009.
    1. SAS Institute Inc. SAS software 9.3. NC, USA: Cary; 2013.
    1. The Diabetes Prevention Program (DPP): Research Group. Description of lifestyle intervention. Diabetes Care. 2002;25:2165–2171.
    1. Bandura A. Social Foundations of Thought and Action: A social cognitive theory. N.J, Prentice Hall: Englewood Cliffs; 1986.
    1. Prochaska JO, DiClemente CC. In: Coping and Substance Use. Shiffman S, Wills T, editor. New York: Academic Press; 1985. Common processes of self-change in smoking, weight control and psychological distress; pp. 345–363.
    1. Albright CL, Steffen AD, Novotny R, Nigg CR, Wilkens LR, Saiki K, Yamada P, Hedemark B, Maddock JE, Dunn AL, Brown WJ. Baseline results from Hawaii’s Na Mikimiki Project: a physical activity intervention tailored to multiethnic postpartum women. Women Health. 2012;52:265–291. doi: 10.1080/03630242.2012.662935.
    1. Marcus BH, Simkin LR. The stages of exercise behavior. J Sports Med Phys Fitness. 1993;33:83–88.
    1. Kristal AR, Glanz K, Curry SJ, Patterson RE. How can stages of change be best used in dietary interventions? J Am Diet Assoc. 1999;99:679–684. doi: 10.1016/S0002-8223(99)00165-0.
    1. Chang MW, Nitzke S, Brown RL, Baumann LC, Oakley L. Development and validation of a self-efficacy measure for fat intake behaviors of low-income women. J Nutr Educ Behav. 2003;35:302–307. doi: 10.1016/S1499-4046(06)60344-8.
    1. Kiernan M, Moore SD, Schoffman DE, Lee K, King AC, Taylor CB, Kiernan NE, Perri MG. Social support for healthy behaviors: scale psychometrics and prediction of weight loss among women in a behavioral program. Obesity (Silver Spring) 2012;20:756–764. doi: 10.1038/oby.2011.293.
    1. IOM (Institutes of Medicine) Weight Gain During Pregnancy: Reexamining the Guidelines. Washington DC: The National Academic Press; 2009.
    1. Borrelli B, Sepinwall D, Ernst D, Bellg AJ, Czajkowski S, Breger R, DeFrancesco C, Levesque C, Sharp DL, Ogedegbe G, Resnick B, Orwig D. A new tool to assess treatment fidelity and evaluation of treatment fidelity across 10 years of health behavior research. J Consult Clin Psychol. 2005;73:852–860.
    1. Phinney JS, Ong AD. Conceptualization and measurement of ethnic identity. J Couns Psychol. 2007;54:271–281.
    1. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114:163–173. doi: 10.1016/j.jad.2008.06.026.
    1. Block G, Gillespie C, Rosenbaum EH, Jenson C. A rapid food screener to assess fat and fruit and vegetable intake. Am J Prev Med. 2000;18:284–288. doi: 10.1016/S0749-3797(00)00119-7.
    1. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986;124:453–469.
    1. Brown WJ, Bauman AE. Comparison of estimates of population levels of physical activity using two measures. Aust N Z J Public Health. 2000;24:520–525. doi: 10.1111/j.1467-842X.2000.tb00503.x.
    1. Chasan-Taber L, Schmidt MD, Roberts DE, Hosmer D, Markenson G, Freedson PS. Development and validation of a pregnancy physical activity questionnaire. Med Sci Sports Exerc. 2004;36:1750–1760. doi: 10.1249/01.MSS.0000142303.49306.0D.
    1. Gunderson EP, Matias SL, Hurston SR, Dewey KG, Ferrara A, Quesenberry CP Jr, Lo JC, Sternfeld B, Selby JV. Study of women, infant feeding, and type 2 diabetes mellitus after GDM pregnancy (SWIFT), a prospective cohort study: methodology and design. BMC Public Health. 2011;11:952. doi: 10.1186/1471-2458-11-952.
    1. Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36:588–594.
    1. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43:203–220. doi: 10.1097/00005650-200503000-00003.
    1. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–396. doi: 10.2307/2136404.
    1. Kim C, McEwen LN, Piette JD, Goewey J, Ferrara A, Walker EA. Risk perception for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care. 2007;30:2281–2286. doi: 10.2337/dc07-0618.
    1. Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661. doi: 10.1136/bmj.e5661.
    1. Eldridge SM, Ashby D, Feder GS. Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care. Clin Trials. 2005;2:91–98. doi: 10.1191/1740774505cn070oa.
    1. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862–1868. doi: 10.2337/diacare.25.10.1862.
    1. Nicholson WK, Wilson LM, Witkop CT, Baptiste-Roberts K, Bennett WL, Bolen S, Barone BB, Golden SH, Gary TL, Neale DM, Bass EB. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Evid Rep Technol Assess (Full Rep) 2008;162:1–96.
    1. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624–1632.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅